The global bioanalytical testing services market size was estimated at USD 4,727.9 million in 2024 and is projected to reach USD 8,019.2 million by 2030, growing at a CAGR of 9.2% from 2025 to 2030. The market growth is due to increasing drug development activities and drug approval processes, increasing complexity of therapeutics, and a rise in outsourcing of testing services.
The development of complex therapeutic modalities, such as gene therapies and biologics, has created a need for specialized bioanalytical testing services. Furthermore, growing technological advancements and increasing R&D investments are also some of the key factors driving market growth.
The continuous developments of cutting-edge technologies, such as High-Throughput Screening (HTS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Next-Generation Sequencing (NGS), have significantly enhanced the precision, speed, and sensitivity of bioanalytical testing. These innovations assist service providers in conducting more complex studies and gaining accurate data on drug efficacy, safety, and pharmacokinetics, among others. Moreover, the integration of automation and Artificial Intelligence (AI) into bioanalytical workflows has streamlined processes, reduced human error, and improved throughput.
In addition, increasing regulatory control and awareness regarding the importance of bioanalytical testing are also fueling the demand for bioanalytical testing services. The introduction of stringent guidelines on drug development, particularly in areas of pharmacokinetics, pharmacodynamics, and bioequivalence testing by several regulatory agencies, such as the U.S. FDA and EMA, led to a rising preference for outsourcing. These guidelines highlight the need for precise and reliable bioanalytical methods to enhance the safety and efficacy of new drugs & biosimilars.
The bioanalytical testing services industry is undergoing significant transformation driven by constant technological innovations. Cell-based assays and flow cytometry have gained adoption due to the growing focus on cell and gene therapies, supporting functional bioactivity and potency evaluations. High-resolution mass spectrometry, including tools like Orbitrap and time-of-flight instruments, has enabled precise quantification of small and large molecules, biomarkers, and therapeutic proteins. Ligand-binding assays, especially ELISA and electrochemiluminescence platforms, remain essential for biologics analysis, particularly in biosimilar and monoclonal antibody development. Bioinformatics and data management platforms are becoming increasingly critical in handling the complex and voluminous datasets generated, offering support for regulatory compliance and audit tracking. Automation and robotics have further streamlined workflows by enhancing sample throughput, reducing manual errors, and improving reproducibility across testing processes.
The bioanalytical testing services industry employs a variety of pricing models, each tailored to specific project needs and client engagement levels. Milestone-based pricing is commonly used for projects with clearly defined phases, such as method development and sample analysis, allowing payments to be tied to the successful completion of deliverables. This model offers predictability for sponsors while aligning compensation with progress for service providers. Fixed-fee models are benefited for routine testing services, including bioequivalence and pharmacokinetic studies, where standardization ensures low variability. These models offer cost transparency and help maintain margins through structured pricing. Value-based pricing is gaining popularity in high-impact areas like oncology or personalized medicine, where compensation is based on the outcome or perceived value of the service. Subscription or retainer models are increasingly adopted for long-term partnerships, giving sponsors recurring access to services or dedicated teams across multiple studies.
The bioanalytical testing services industry is undergoing rapid innovation, particularly through the integration of high-resolution mass spectrometry, next-generation sequencing (NGS), and hybrid LC-MS/MS platforms. These advancements have dramatically improved the sensitivity and specificity of testing biologics, small molecules, and biomarkers.
The sector has seen a steady rise in mergers and acquisitions, driven by the need for companies to expand their technological capabilities and global reach. Strategic acquisitions are often focused on strengthening niche service offerings such as large molecule bioanalysis, cell & gene therapy testing, and immunogenicity assays. For instance, in March 2024, Pace Analytical Services announced the acquisition of Lebanon, a New Jersey laboratory facility, from Curia. The acquisition aimed to support emerging drug development partners by providing rapid and expert development and commercial analytical laboratory services across the biopharma industry.
Regulatory frameworks from agencies such as the FDA, EMA, and PMDA have a profound impact on bioanalytical testing. Stricter guidance around bioanalytical method validation, data integrity, and Good Laboratory Practices (GLP) compliance has necessitated robust QA/QC systems and digital traceability tools.
To meet the growing complexity of drug development pipelines, bioanalytical service providers are diversifying their offerings. There is increasing demand for integrated large molecule services such as ADA, NAb, and cytokine profiling, customized assay development, and multiplex bioanalytical platforms.
North America remains the hub for advanced bioanalytical testing services, but there is a strong momentum in Asia-Pacific and parts of Europe. India, China, and South Korea are emerging as strategic centers due to a combination of skilled scientific talent, lower operational costs, and growing domestic pharmaceutical pipelines.
The small molecule segment captured the largest market share of 55.3% in 2024. The growth of the segment can be attributed to medical breakthroughs related to small molecules and unmet medical needs. Besides, bioanalytical testing of small molecules is crucial for gaining insights into their ADME properties, determining the appropriate dosage, evaluating the therapeutic effectiveness, and safeguarding patient well-being.
The large molecule segment is projected to experience the fastest CAGR over the projected period due to the rising development and commercialization of biologics and biosimilars. Unlike small molecules, large molecule drugs such as monoclonal antibodies, therapeutic proteins, and gene therapies require highly specialized and sensitive analytical techniques for accurate assessment of pharmacokinetics, immunogenicity, and stability.
The bioavailability segment dominated the market in 2024. The segment’s growth is mainly driven due to its significant role in drug development and regulatory approval activities. Bioavailability studies are essential in determining how efficiently and quickly a drug reaches systemic circulation, directly influencing dosage design, therapeutic efficacy, and safety profiles. This segment is particularly vital for evaluating both new chemical entities and generic formulations, ensuring they perform consistently and meet required bioequivalence standards.
The bioequivalence segment is expected to experience the fastest CAGR during the forecast period. The growth is due to the rising emphasis on generic drug development across global pharmaceutical pipelines. Regulatory agencies require bioequivalence studies to confirm that generic formulations match the safety, efficacy, and pharmacokinetic profiles of their branded counterparts. This has made bioequivalence testing a viable option for cost-effective drug development.
The sample analysis segment dominated the market in 2024. This segment includes several procedures, such as quantification of active pharmaceutical ingredients, detection of metabolites, and stability testing, each vital for regulatory submissions and clinical trial progression. As drug pipelines grow more complex, particularly with biologics and targeted therapies, the demand for precise and high-throughput sample analysis will also increase.
The sample collection and preparation segment is expected to experience the fastest CAGR during the forecast period. The growth is due to the increasing complexity of drug development processes, which necessitate precise and efficient sample preparation techniques to ensure accurate analytical results. Advancements in automation and miniaturization are enhancing the efficiency and reliability of sample preparation, making it a critical component in bioanalytical workflows.
The pharma & biopharma companies segment dominated the market in 2024. The growth of the segment is due to the rising need for outsourcing specialized testing across the drug development lifecycle. These companies increasingly rely on external service providers to manage the complex and highly regulated nature of bioanalytical workflows, including pharmacokinetic studies, immunogenicity assessments, and biomarker validation. Outsourcing assists them in accelerating timelines, reducing in-house infrastructure costs, and gaining access to technical expertise and advanced platforms.
The CRO segment is expected to witness the fastest CAGR over the analysis timeframe. With the growing number of large and small molecule-based therapeutics coming to market, the CRO increasingly requires bioanalytical testing services with standard regulation compliance, meeting a wide range of international standards and guidelines for evaluating highly sensitive drug samples. Besides, increasing complex innovations in the CRO have caused a rise in demand for quality and technologically advanced bioanalytical testing services from preclinical to clinical and commercial scales, further expanding the market growth.
The North America bioanalytical testing services industry accounted for the largest global share of 47.40% in 2024. The growth in the region is mainly due to the increasing demand for biopharmaceuticals, constant technological advancements, and increasing investment in R&D of new drugs. Furthermore, growing innovations in mass spectrometry, chromatography, and other analytical methods have enhanced the sensitivity, specificity, and throughput of testing processes. These technologies have enabled laboratories to conduct more precise and efficient analyses, facilitating faster drug development timelines and reducing costs.
The bioanalytical testing services industry in the U.S. is driven by the presence of several pharmaceutical and biotechnology companies and outsourcing firms in the country. Companies such as Alcami Corporation, a U.S.-based CDMO offering analytical development services, support various therapeutic modalities, ranging from small molecules to biologics. Furthermore, biotechnology and pharmaceutical companies are continuously innovating and adapting to meet the growing demand for more effective biotherapeutic solutions. This dynamic landscape has accelerated the need for advanced approaches in biologics development, prompting an increase in strategic partnerships with outsourcing partners. These collaborations would allow companies to leverage specialized expertise and innovative technologies, further accelerating the drug development process and enhancing their ability to bring novel therapies to market.
The bioanalytical testing services industry in Europe is experiencing growth due to the advancements in technology, the increasing number of clinical trials, and the presence of key players offering advanced analytical testing solutions. Europe has become a hub for clinical research due to its diverse patient populations and well-established regulatory frameworks. The need for proper bioanalytical testing is essential to monitor pharmacokinetics, pharmacodynamics, and safety profiles of new drugs. Therefore, the increasing number of clinical studies in the region would increase the demand for bioanalytical services, further necessitating the need for service providers to expand their capabilities and offerings.
The bioanalytical testing services industry in the UK held a significant share in 2024. The country’s market growth is driven by extensive R&D initiatives and clinical trials being undertaken to address the challenges posed by various infectious diseases. These companies often require bioanalytical testing services to assess their pharmaceutical products' safety, efficacy, and quality, contributing to market growth.
The bioanalytical testing services industry in France is driven by the country’s growing demand for biologics, such as gene therapies, cell-based therapies, and monoclonal antibodies. According to an article published by NCBI in February 2024, 44 new cell and gene therapies are anticipated to enter the French market by 2030, and an estimated annual number of treated patients is expected to rise from 1,653 in 2023 to over 69,400 by 2030. These complex products require rigorous testing for safety, efficacy, and quality, which will further drive the demand for specialized bioanalytical services.
The bioanalytical testing services industry in Germany is anticipated to grow due to increasing demand for outsourcing services from major companies such as Novartis, Sanofi, Roche, GlaxoSmithKline, and AstraZeneca.Furthermore, several strategic initiatives, such as expansion and mergers and acquisitions by outsourcing firms, are also driving the demand for bioanalytical testing services in the country.
The Asia Pacific bioanalytical testing services industry is projected to grow at the fastest CAGR over the forecast period. The growth of the market is attributed to the increasing pharmaceutical & biotechnology activities, rising healthcare expenditure, and increasing investments by pharmaceutical and biotechnology companies. Furthermore, key companies are opening new facilities and forming collaborations and partnerships to increase the reach of their offerings to various locations in the region. For instance, in July 2023, LabCorp announced the opening of a new kit production facility by expanding its immunotoxicology & immunology lab in China. These expanded operations will further increase China’s drug development capabilities to advance a pipeline of innovative therapies.
The bioanalytical testing services industry in China is expected to grow over the forecast period. China has become an attractive destination for outsourcing clinical trials due to its large population, diverse patient pool, and cost-effectiveness. As a result, both domestic and international pharmaceutical companies outsource their clinical trials to CROs in China, driving the demand for bioanalytical testing services.
Japan bioanalytical testing services industry is witnessing significant growth over the forecast period. The country’s growth is due to the expanding biopharmaceutical sector, a strong focus on precision medicine, and rising demand for biologics and biosimilars. The aging population and increasing prevalence of chronic diseases are fueling the development of complex therapeutic agents that require advanced testing solutions.
India bioanalytical testing services industry is witnessing considerable growth, and the growth is attributed to low costs, the availability of industry experts, and the presence of WHO-cGMP-compliant facilities. India has become one of the most preferred sites for clinical trials due to the presence of the largest patient pool, a developing healthcare sector, a large number of educated physicians, and cost competitiveness.
The Latin America bioanalytical testing services industry is projected to grow over the forecast period. The growth in the region is due to expanding pharmaceutical and biotechnology sectors, increased clinical trial activity, and rising demand for both small and large molecule drug testing. Countries like Brazil are emerging as key hubs due to their growing R&D infrastructure, favorable regulatory environments, and diverse patient populations that support efficient clinical research.
The bioanalytical testing services industry in Brazil is expected to grow over the forecast period. The country's growth is driven by the expanding pharmaceutical industry, increasing number of clinical trials, and rising investment in biologics and biosimilars. Brazil’s favorable regulatory reforms, along with growing participation in global drug development, are encouraging both domestic and international CROs to strengthen their testing capabilities in the region.
Key players in the bioanalytical testing services industry are actively expanding their service portfolios, investing in advanced analytical technologies, and pursuing strategic partnerships to strengthen their global presence. Leading CROs and specialized service providers are enhancing capabilities in complex assay development, large molecule analysis, and cell and gene therapy testing to meet evolving client needs. For instance, in August 2024, SGS introduced its new specialized bioanalytical testing services in Hudson, New Hampshire, North America. Through these services, the company provides advanced bioanalytical services to both biopharmaceutical and pharmaceutical companies.
The following are the leading companies in the bioanalytical testing services market. These companies collectively hold the largest market share and dictate industry trends.
In September 2024, Thermo Fisher Scientific expanded its bioanalytical testing services in Europe. The expansion aimed to offer services to pharmaceutical and biotech customers with advanced laboratory services.
In September 2024, Laboratory Corporation of America Holdings announced the completion of its laboratory in Greenfield. The expansion aimed to increase its global molecular bioanalytical capacity.
In June 2024, Pace Analytical Services announced the acquisition of Lebanon, a New Jersey laboratory facility from Curia. The acquisition aimed to support emerging drug development partners by providing rapid and expert development and commercial analytical laboratory services across the biopharma industry.
Report Attribute |
Details |
Market size in 2025 |
USD 5.16 billion |
Revenue forecast in 2030 |
USD 8.02 billion |
Growth rate |
CAGR of 9.21% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Molecule, test, workflow, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; South Africa; Saudi Arabia, UAE; Kuwait |
Key companies profiled |
Thermo Fisher Scientific Inc; ICON Plc; Charles River Laboratories International; IQVIA Inc.; Syneos Health; SGS SA; Labcorp; Intertek Group Plc; Pace Analytical Services LLC; Wuxi AppTec |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global bioanalytical testing services market report based on molecule, test, workflow, end use, and region:
Molecule Outlook (Revenue, USD Million, 2018 - 2030)
Small Molecule
Large Molecule
LC-MS Studies
Immunoassays
Pharmacokinetics (PK)
ADA Assay
Other
Other Large Molecule Tests
Test Outlook (Revenue, USD Million, 2018 - 2030)
ADME
In-vivo
In-vitro
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Bioavailability
Bioequivalence
Biomarker Testing
Cell-based Assay
Virology Testing
Other Tests
Workflow Outlook (Revenue, USD Million, 2018 - 2030)
Sample Collection and Preparation
Sample Collection, Handling and Storage
Protein Precipitation
Liquid-Liquid Extraction
Solid Phase Extraction
Others
Method Development and Validation
Sample Analysis
Hyphenated technique
Chromatographic technique
Electrophoresis
Ligand Binding Assay
Mass Spectrometry
Spectroscopic Techniques
Nuclear Magnetic Resonance (NMR)
Others
Genomic and Molecular Techniques
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Others
Other processes
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Pharma & BioPharma Companies
CDMO
CRO
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Netherlands
Switzerland
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Indonesia
Malaysia
Singapore
South Korea
Thailand
Taiwan
Australia
Latin America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Israel
Kuwait
b. The global bioanalytical testing services market size was estimated at USD 4.73 billion in 2024 and is expected to reach USD 5.16 billion in 2025.
b. The global bioanalytical testing services market is expected to grow at a compound annual growth rate of 9.21% from 2025 to 2030 to reach USD 8.02 billion by 2030.
b. North America dominated the bioanalytical testing services market with a share of 47.40% in 2024. This is attributable to the fact that it is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals.
b. Some key bioanalytical testing services market players are PPD, Inc.; Laboratory Corporation of America Holdings; ICON plc.; Charles River Laboratories International; IQVIA; SGS SA; Intertek Group; and Pace Analytical Services, LLC., among others
b. Key factors that are driving the bioanalytical testing services market growth include the increasing frequency of outsourcing R&D activities by the major pharmaceutical companies to focus on their core competencies.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Purchased Database
1.3.3. GVR’s Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.4. Information or Data Analysis
1.4.1. Information Analysis
1.4.2. Market Formulation & Data Visualization
1.4.3. Data Validation & Publishing
1.5. Model Details
1.5.1. Commodity Flow Analysis (Model 1)
1.5.2. Top Down Market Estimation (Model 2)
1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
1.5.4. Multivariate Analysis (Model 4)
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Investments & Funding Perspective
3.5. Clinical Trials Volume Analysis, (2024)
3.5.1. Total Number of Clinical Trials, by Region (2024)
3.5.2. Total Number of Clinical Trials, by Phase (2024)
3.5.3. Total Number of Clinical Trials, by Study Design (2024)
3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
3.6. Technology Landscape
3.7. Pricing Model Analysis
3.8. Industry Analysis Tools
3.8.1. Porter’s Five Forces Analysis
3.8.2. PESTEL Analysis
3.8.3. COVID-19 Impact Analysis
Chapter 4. Bioanalytical Testing Services Market: Molecule Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Bioanalytical Testing Services Market; Molecule Movement Analysis
4.3. Bioanalytical Testing Services Size & Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
4.4. Small Molecule
4.4.1. Small molecule market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Large Molecule
4.5.1. Large molecule market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. LC-MS studies
4.5.2.1. LC-MS studies market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Immunoassays
4.5.3.1. Immunoassays market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.2. Pharmacokinetics (PK)
4.5.3.2.1. Pharmacokinetics (PK) market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.3. ADA assay
4.5.3.3.1. ADA assay market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.4. Other
4.5.3.4.1. Other large molecule tests market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Other large molecule tests
4.5.4.1. Other large molecule tests market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Bioanalytical Testing Services Market: Test Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Bioanalytical Testing Services Market; Test Movement Analysis
5.3. Bioanalytical Testing Services Size & Trend Analysis, by Test, 2018 to 2030 (USD Million)
5.4. ADME
5.4.1. ADME market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Pharmacokinetics (PK)
5.5.1. Pharmacokinetics (PK) market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Pharmacodynamics (PD)
5.6.1. Pharmacodynamics (PD) market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Bioavailability
5.7.1. Bioavailability market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Bioequivalence
5.8.1. Bioequivalence market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Biomarker testing
5.9.1. Biomarker testing market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Cell-based assay
5.10.1. Cell-based assay market estimates and forecasts 2018 to 2030 (USD Million)
5.11. Virology testing
5.11.1. Virology testing market estimates and forecasts 2018 to 2030 (USD Million)
5.12. Other tests
5.12.1. Other tests market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Bioanalytical Testing Services Market: Workflow Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Bioanalytical Testing Services Market; Workflow Movement Analysis
6.3. Bioanalytical Testing Services Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Sample Collection and Preparation
6.4.1. Sample collection and preparation market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Sample collection, handling and storage
6.4.2.1. Sample collection, handling and storage market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Protein precipitation
6.4.3.1. Protein precipitation market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Liquid-Liquid extraction
6.4.4.1. Liquid-Liquid extraction market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Solid Phase extraction
6.4.5.1. Solid phase extraction market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Others
6.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Method Development and Validation
6.5.1. Method development and validation market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Sample analysis
6.6.1. Sample analysis market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Hyphenated technique
6.6.2.1. Hyphenated technique market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Chromatographic technique
6.6.3.1. Chromatographic technique market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Electrophoresis
6.6.4.1. Electrophoresis market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Ligand binding assay
6.6.5.1. Ligand binding assay market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Mass spectrometry
6.6.6.1. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Spectroscopic techniques
6.6.7.1. Spectroscopic techniques market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7.2. Nuclear Magnetic Resonance (NMR)
6.6.7.2.1. Nuclear Magnetic Resonance (NMR) market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7.3. Others
6.6.7.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Genomic and Molecular Techniques
6.6.8.1. Genomic and molecular techniques market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8.2. Polymerase Chain Reaction (PCR)
6.6.8.2.1. Polymerase Chain Reaction (PCR) market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8.3. Next-Generation Sequencing (NGS)
6.6.8.3.1. Next-Generation Sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8.4. Others
6.6.8.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Other processes
6.7.1. Other processes market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Bioanalytical Testing Services Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Bioanalytical Testing Services Market; End Use Movement Analysis
7.3. Bioanalytical Testing Services Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Pharma & BioPharma Companies
7.4.1. Pharma & biopharma companies market estimates and forecasts 2018 to 2030 (USD Million)
7.5. CDMO
7.5.1. CDMO market estimates and forecasts 2018 to 2030 (USD Million)
7.6. CRO
7.6.1. CRO market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
8.3. North America
8.3.1. North America bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key country dynamics
8.3.2.2. Competitive scenario
8.3.2.3. Regulatory framework
8.3.2.4. U.S. bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key country dynamics
8.3.3.2. Competitive scenario
8.3.3.3. Regulatory framework
8.3.3.4. Canada bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.4. Mexico
8.3.4.1. Key country dynamics
8.3.4.2. Competitive scenario
8.3.4.3. Regulatory framework
8.3.4.4. Mexico bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4. Europe
8.4.1. Europe bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Germany bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3. UK
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. UK bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.4. France
8.4.4.1. Key country dynamics
8.4.4.2. Competitive scenario
8.4.4.3. Regulatory framework
8.4.4.4. France bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key country dynamics
8.4.5.2. Competitive scenario
8.4.5.3. Regulatory framework
8.4.5.4. Italy bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key country dynamics
8.4.6.2. Competitive scenario
8.4.6.3. Regulatory framework
8.4.6.4. Spain bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.7. Netherlands
8.4.7.1. Key country dynamics
8.4.7.2. Competitive scenario
8.4.7.3. Regulatory framework
8.4.7.4. Netherlands bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.8. Switzerland
8.4.8.1. Key country dynamics
8.4.8.2. Competitive scenario
8.4.8.3. Regulatory framework
8.4.8.4. Switzerland bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.9. Denmark
8.4.9.1. Key country dynamics
8.4.9.2. Competitive scenario
8.4.9.3. Regulatory framework
8.4.9.4. Denmark bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.10. Sweden
8.4.10.1. Key country dynamics
8.4.10.2. Competitive scenario
8.4.10.3. Regulatory framework
8.4.10.4. Sweden bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.11. Norway
8.4.11.1. Key country dynamics
8.4.11.2. Competitive scenario
8.4.11.3. Regulatory framework
8.4.11.4. Norway bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.2. Japan
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Japan bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.3. China
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. China bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.4. India
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. India bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. South Korea bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.6. Australia
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Australia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.7. Thailand
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Thailand bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.8. Indonesia
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Indonesia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.9. Malaysia
8.5.9.1. Key country dynamics
8.5.9.2. Competitive scenario
8.5.9.3. Regulatory framework
8.5.9.4. Malaysia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.10. Singapore
8.5.10.1. Key country dynamics
8.5.10.2. Competitive scenario
8.5.10.3. Regulatory framework
8.5.10.4. Singapore bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.11. Taiwan
8.5.11.1. Key country dynamics
8.5.11.2. Competitive scenario
8.5.11.3. Regulatory framework
8.5.11.4. Taiwan bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Latin America
8.6.1. Latin America bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Brazil bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Argentina bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.4. Colombia
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Colombia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. MEA
8.7.1. MEA bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. South Africa bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Saudi Arabia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key country dynamics
8.7.4.2. Competitive scenario
8.7.4.3. Regulatory framework
8.7.4.4. UAE bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key country dynamics
8.7.5.2. Competitive scenario
8.7.5.3. Regulatory framework
8.7.5.4. Kuwait bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Company Market Position Analysis, 2024
9.3. Company Profiles
9.3.1. Thermo Fisher Scientific Inc
9.3.1.1. Company overview
9.3.1.2. Financial performance
9.3.1.3. Service benchmarking
9.3.1.4. Strategic initiatives
9.3.2. ICON Plc
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Service benchmarking
9.3.2.4. Strategic initiatives
9.3.3. Charles River Laboratories International
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Service benchmarking
9.3.3.4. Strategic initiatives
9.3.4. IQVIA Inc.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Service benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Syneos Health
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Service benchmarking
9.3.5.4. Strategic initiatives
9.3.6. SGS SA
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Service benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Labcorp
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Service benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Intertek Group Plc
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Service benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Pace Analytical Services LLC
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Service benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Wuxi AppTec
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Service benchmarking
9.3.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 Global Bioanalytical Testing Services market, by region, 2018 - 2030 (USD Million)
Table 3 Global Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 4 Global Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 5 Global Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 6 Global Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 7 Global Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 8 Global Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 9 Global Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 10 Global ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 11 Global Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 12 Global Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 13 North America Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 14 North America Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 15 North America Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 16 North America Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 17 North America Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 18 North America Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 19 U.S. Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 20 U.S. Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 21 U.S. Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 22 U.S. Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 23 U.S. Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 24 U.S. Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 25 Canada Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 26 Canada Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 27 Canada Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 28 Canada Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 29 Canada Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 30 Mexico Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 31 Mexico Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 32 Mexico Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 33 Mexico Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 34 Mexico Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 35 Europe Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 36 Europe Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 37 Europe Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 38 Europe Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 39 Europe Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 40 Europe Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 41 Germany Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 42 Germany Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 43 Germany Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 44 Germany Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 45 Germany Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 46 UK Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 47 UK Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 48 UK Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 49 UK Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 50 UK Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 51 France Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 52 France Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 53 France Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 54 France Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 55 France Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 56 Italy Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 57 Italy Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 58 Italy Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 59 Italy Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 60 Italy Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 61 Spain Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 62 Spain Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 63 Spain Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 64 Spain Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 65 Spain Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 66 Denmark Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 67 Denmark Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 68 Denmark Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 69 Denmark Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 70 Denmark Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 71 Sweden Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 72 Sweden Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 73 Sweden Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 74 Sweden Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 75 Sweden Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 76 Norway Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 77 Norway Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 78 Norway Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 79 Norway Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 80 Norway Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 81 Netherlands Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 82 Netherlands Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 83 Netherlands Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 84 Netherlands Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 85 Netherlands Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 86 Switzerland Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 87 Switzerland Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 88 Switzerland Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 89 Switzerland Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 90 Switzerland Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 91 Asia Pacific Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 92 Asia Pacific Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 93 Asia Pacific Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 94 Asia Pacific Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 95 Asia Pacific Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 96 Asia Pacific Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 97 China Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 98 China Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 99 China Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 100 China Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 101 China Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 102 Japan Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 103 Japan Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 104 Japan Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 105 Japan Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 106 Japan Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 107 India Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 108 India Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 109 India Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 110 India Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 111 India Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 112 South Korea Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 113 South Korea Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 114 South Korea Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 115 South Korea Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 116 South Korea Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 117 Australia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 118 Australia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 119 Australia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 120 Australia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 121 Australia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 122 Thailand Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 123 Thailand Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 124 Thailand Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 125 Thailand Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 126 Thailand Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 127 Indonesia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 128 Indonesia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 129 Indonesia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 130 Indonesia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 131 Indonesia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 132 Malaysia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 133 Malaysia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 134 Malaysia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 135 Malaysia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 136 Malaysia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 137 Singapore Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 138 Singapore Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 139 Singapore Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 140 Singapore Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 141 Singapore Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 142 Taiwan Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 143 Taiwan Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 144 Taiwan Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 145 Taiwan Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 146 Taiwan Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 147 Latin America Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 148 Latin America Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 149 Latin America Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 150 Latin America Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 151 Latin America Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 152 Latin America Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 153 Brazil Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 154 Brazil Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 155 Brazil Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 156 Brazil Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 157 Brazil Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 158 Argentina Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 159 Argentina Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 160 Argentina Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 161 Argentina Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 162 Argentina Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 163 Colombia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 164 Colombia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 165 Colombia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 166 Colombia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 167 Colombia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 168 MEA Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 169 MEA Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 170 MEA Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 171 MEA Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 172 MEA Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 173 MEA Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 174 South Africa Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 175 South Africa Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 176 South Africa Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 177 South Africa Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 178 South Africa Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 179 Saudi Arabia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 180 Saudi Arabia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 181 Saudi Arabia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 182 Saudi Arabia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 183 Saudi Arabia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 184 UAE Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 185 UAE Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 186 UAE Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 187 UAE Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 188 UAE Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 189 Kuwait Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 190 Kuwait Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 191 Kuwait Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 192 Kuwait Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 193 Kuwait Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 194 Israel Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 195 Israel Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 196 Israel Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 197 Israel Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 198 Israel Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Bioanalytical Testing Services Market , Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 PESTEL Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Bioanalytical Testing Services Market for Small Molecule, 2018 - 2030 (USD Million)
Fig. 15 Global Bioanalytical Testing Services Market for Large Molecule, 2018 - 2030 (USD Million)
Fig. 16 Global Bioanalytical Testing Services Market for LC-MS Studies, 2018 - 2030 (USD Million)
Fig. 17 Global Bioanalytical Testing Services Market for Immunoassays, 2018 - 2030 (USD Million)
Fig. 18 Global Bioanalytical Testing Services Market for PK, 2018 - 2030 (USD Million)
Fig. 19 Global Bioanalytical Testing Services Market for ADA, 2018 - 2030 (USD Million)
Fig. 20 Global Bioanalytical Testing Services Market for Other, 2018 - 2030 (USD Million)
Fig. 21 Global Bioanalytical Testing Services Market for Other Large Molecule Tests, 2018 - 2030 (USD Million)
Fig. 22 Global Bioanalytical Testing Services Market for ADME, 2018 - 2030 (USD Million)
Fig. 23 Global Bioanalytical Testing Services Market for In-Vivo, 2018 - 2030 (USD Million)
Fig. 24 Global Bioanalytical Testing Services Market for In-Vitro, 2018 - 2030 (USD Million)
Fig. 25 Global Bioanalytical Testing Services Market for PK, 2018 - 2030 (USD Million)
Fig. 26 Global Bioanalytical Testing Services Market for PD, 2018 - 2030 (USD Million)
Fig. 27 Global Bioanalytical Testing Services Market for Bioavailability, 2018 - 2030 (USD Million)
Fig. 28 Global Bioanalytical Testing Services Market for Bioequivalence, 2018 - 2030 (USD Million)
Fig. 29 Global Bioanalytical Testing Services Market for Biomarker Testing, 2018 - 2030 (USD Million)
Fig. 30 Global Bioanalytical Testing Services Market for Cell-based Assay, 2018 - 2030 (USD Million)
Fig. 31 Global Bioanalytical Testing Services Market for Virology Testing, 2018 - 2030 (USD Million)
Fig. 32 Global Bioanalytical Testing Services Market for Others, 2018 - 2030 (USD Million)
Fig. 33 Global Bioanalytical Testing Services Market for Sample Preparation, 2018 - 2030 (USD Million)
Fig. 34 Global Bioanalytical Testing Services Market for Protein Precipitation, 2018 - 2030 (USD Million)
Fig. 35 Global Bioanalytical Testing Services Market for Liquid-Liquid Extraction, 2018 - 2030 (USD Million)
Fig. 36 Global Bioanalytical Testing Services Market for Solid Phase Extraction, 2018 - 2030 (USD Million)
Fig. 37 Global Bioanalytical Testing Services Market for Sample Analysis, 2018 - 2030 (USD Million)
Fig. 38 Global Bioanalytical Testing Services Market for Hyphenated technique, 2018 - 2030 (USD Million)
Fig. 39 Global Bioanalytical Testing Services Market for Chromatographic technique, 2018 - 2030 (USD Million)
Fig. 40 Global Bioanalytical Testing Services Market for Electrophoresis, 2018 - 2030 (USD Million)
Fig. 41 Global Bioanalytical Testing Services Market for Ligand Binding Assay, 2018 - 2030 (USD Million)
Fig. 42 Global Bioanalytical Testing Services Market for Mass Spectrometry, 2018 - 2030 (USD Million)
Fig. 43 Global Bioanalytical Testing Services Market for Nuclear Magnetic Resonance, 2018 - 2030 (USD Million)
Fig. 44 Global Bioanalytical Testing Services Market for Others, 2018 - 2030 (USD Million)
Fig. 45 Global Bioanalytical Testing Services Market for Pharma & BioPharma Companies, 2018 - 2030 (USD Million)
Fig. 46 Global Bioanalytical Testing Services Market for CDMO, 2018 - 2030 (USD Million)
Fig. 47 Global Bioanalytical Testing Services Market for CRO, 2018 - 2030 (USD Million)
Fig. 48 Regional Outlook, 2024 & 2030
Fig. 49 North America Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 51 Canada Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Mexico Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 53 Europe Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Germany Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 UK Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 France Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 Italy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Spain Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 Netherlands Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Switzerland Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 Denmark Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Sweden Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Norway Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Asia Pacific Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 Japan Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 China Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 India Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Australia Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 South Korea Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Thailand Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 71 Indonesia Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Malaysia Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 73 Singapore Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 Taiwan Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 75 Latin America Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 Brazil Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 77 Argentina Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 78 Colombia Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 79 Middle East and Africa Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 80 South Africa Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 81 Saudi Arabia Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 82 UAE Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 83 Kuwait Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 84 Israel Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Market Segmentation
Report content
Qualitative Analysis
Quantitative Analysis
Research Methodology
Grand View Research employs a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
• Market drivers and restraints, along with their current and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and expected capacity additions up to 2030
We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.
Primary validation
This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts, and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation but also provide critical insights into the market, current business scenario, and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:
• Market-leading companies
• Raw material suppliers
• Product distributors
• Buyers
The key objectives of primary research are as follows:
• To validate our data in terms of accuracy and acceptability
• To gain an insight in to the current market and future expectations
Data Collection Matrix
Perspective |
Primary research |
Secondary research |
Supply-side |
|
|
Demand-side |
|
|
Industry Analysis Matrix
Qualitative analysis |
Quantitative analysis |
|
|
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."